Emerging Health IssuesMedical Technology

Is CAR-T a Bust?

The Food and Drug Administration put a temporary hold to Juno Therapeutics’ clinical trials for CAR-T (Chimeric Antigen Receptor (CAR) T-Cell) therapies after three deaths related to swelling in the brain. Read article here….

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.